Review ArticlePharmacognosy ReviewsVol. 19 | Issue 37 | pp. 119–126Open access
The Case for Cannabidiol-Integration of Eastern and Western Medical Traditions and the Promise for the Future: A Narrative Review and Commentary
- 1*,
- 2,
- 3,
- 4,
- 5
- 1 Medicine and Social Sciences, The University of Maine, Orono, Maine, UNITED STATES OF AMERICA.
- 2 Vectura Fertin Pharma, 4058 Basel, SWITZERLAND.
- 3 DR CBD, Ltd., BangnaNuea, Bagna, Bangkok, THAILAND.
- 4 College of Oriental Medicine, Rangsit University, Pathum Thani, THAILAND.
- 5 College of Public Health, University of South Florida, Tampa, Florida, UNITED STATES OF AMERICA.
Published in Pharmacognosy Reviews
Correspondence: Peter Pressman
Medicine and Social Sciences, The University of Maine, Orono, Maine, UNITED STATES OF AMERICA.
Email: peter.pressman@maine.edu
- Received:
- Dec 27, 2024
- Accepted:
- May 15, 2025
- DOI:
- peter.pressman@maine.edu
How to cite
Pressman, P., Hoeng, J., Padmindra, P., Warinhomhoun, S., & Hayes, W. The Case for Cannabidiol-Integration of Eastern and Western Medical Traditions and the Promise for the Future: A Narrative Review and Commentary. Pharmacognosy Reviews, 19(37), 119–126. https://doi.org/peter.pressman@maine.edu
Abstract
Our intent in the following narrative review and commentary is to underscore the importance of critically re-exploring ancient and enduring medical traditions. We support a view that rediscovering and augmenting the elements of the past, especially in the context of Eastern traditions, will inform and strengthen the global future. In the absence of the historical and multicultural perspective, it could be argued that we have become rather myopic or focused within discrete silos; we seem continually to re-invent the wheel in successively refined form, without truly evaluating foundations, traditions, and history of use. This situation suggests that technologically sophisticated investigators and clinicians are not necessarily aware of the full spectrum of the safety, efficacy, clinical indications, and guidelines for the use of many naturally sourced pharmacologic formulations with a remarkably long history of widespread use, and with implications for valuable and innovative drug development. We discuss Cannabidiol (CBD) as illustrative of such an opportunity.
Keywords
Subject
Article metadata
| Title | The Case for Cannabidiol-Integration of Eastern and Western Medical Traditions and the Promise for the Future: A Narrative Review and Commentary |
|---|---|
| Authors | Peter Pressman; Julia Hoeng; Pornchai Padmindra; Sakan Warinhomhoun; Wallace Hayes |
| Affiliations | Medicine and Social Sciences, The University of Maine, Orono, Maine, UNITED STATES OF AMERICA.; Vectura Fertin Pharma, 4058 Basel, SWITZERLAND.; DR CBD, Ltd., BangnaNuea, Bagna, Bangkok, THAILAND.; College of Oriental Medicine, Rangsit University, Pathum Thani, THAILAND.; College of Public Health, University of South Florida, Tampa, Florida, UNITED STATES OF AMERICA. |
| Corresponding author | peter.pressman@maine.edu |
| Journal | Pharmacognosy Reviews |
| Volume / Issue | Vol. 19, Issue 37 |
Also in this issue
- Natural Bioactives Targeting the GLP-1 Pathway: A Promising Approach for Diabetes Managementpp. 1–14
- Unraveling Advanced Glycation End Products: Mechanisms, Pathophysiology, and Emerging Natural Therapeutic Interventionspp. 15–22
- Ecological and Medicinal Importance of Ficus microcarpa: Unveiling the Diversity of a Versatile Plantqpp. 23–29
- Ayurvedic Concept of Garbhini Paricharya: A Critical Reviewpp. 30–38
- Exploring the Potential of Traditional Medicinal Plants for Central Nervous System Related Activitypp. 39–47